UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
18.79
-0.45 (-2.34%)
Aug 29, 2025, 10:56 AM - Market open
UroGen Pharma Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$28.50
Upside
+51.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $36 | Buy | Initiates | $36 | +91.59% | Aug 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $40 | Strong Buy | Maintains | $50 → $40 | +112.88% | Aug 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +33.05% | Aug 7, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +33.05% | Aug 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +166.10% | Jul 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +33.05% | Jul 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +166.10% | Jun 16, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $31 | Buy | Maintains | $10 → $31 | +64.98% | Jun 13, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $23 → $47 | Buy | Maintains | $23 → $47 | +150.13% | Jun 13, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $15 → $30 | Strong Buy | Maintains | $15 → $30 | +59.66% | Jun 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +33.05% | Jun 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $36 → $10 | Buy | Maintains | $36 → $10 | -46.78% | Jun 3, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $40 → $15 | Strong Buy | Maintains | $40 → $15 | -20.17% | May 23, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $16 → $3 | Hold | Maintains | $16 → $3 | -84.03% | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +192.71% | May 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.